Product Name: Rituximab Injection
Strength: 100 mg/10 mL
Form: Concentrate for Intravenous Infusion
Category: Monoclonal Antibody / Immunosuppressant
Indication: Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with Polyangiitis, Microscopic Polyangiitis
Rituximab 100 mg/10 mL Injection is a monoclonal antibody that targets CD20-positive B cells, used in the treatment of certain blood cancers and autoimmune diseases. It is widely prescribed for non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL), and rheumatoid arthritis, as well as rare inflammatory conditions like granulomatosis with polyangiitis and microscopic polyangiitis.
